In this lecture, Dr. Yassir Javaid will present a comprehensive patient case who suffered a cardiovascular event while revisiting different guidelines and trials data to answer the question: Was the Cardiovascular event preventable?
1. Help define/identify the typical T2D primary prevention patient.
2. Reinforce different guidelines and their applicability.
3. Focus on GLP-1 RA CVOTs; specifically, REWIND.
4. Dulaglutide as a treatment option for such patients.
MA (Cantab) FRCP FRCGP PGDip Cardiology
Cardiovascular Lead East Midlands Clinical Network